Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 76–90 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2763 Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) Gene Sequencing Test This test identifies pathogenic variants in the MLC1 and GLIALCAM genes associated with Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). It provides a definitive m...	Whole blood (10 mL, min. 5 mL) in two Lavender Top EDTA tubes	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MLC1 gene", "Pathogenic variants in GLIALCAM gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications"] Indications ["Suspected diagnosis of MLC", "Family history of MLC", "Macrocephaly with neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: G93.49, E75.29, Z15.89 Clinical summary This test identifies pathogenic variants in the MLC1 and GLIALCAM genes associated with Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). It provides a definitive molecular diagnosis for this rare genetic disorder.
TEST-2590 MMP13 Gene Metaphyseal Anadysplasia Type 1 Genetic Test This test identifies pathogenic variants within the MMP13 gene associated with metaphyseal anadysplasia type 1.	Peripheral whole blood (EDTA) or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MMP13 gene", "Copy number variations in MMP13"] Parameters [] Preparation [] Indications ["Diagnosis of metaphyseal anadysplasia type 1", "Genetic counselling for families with skeletal dysplasia"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q78.5 Clinical summary This test identifies pathogenic variants within the MMP13 gene associated with metaphyseal anadysplasia type 1.
TEST-3153 MPL Gene Congenital Amegakaryocytic Thrombocytopenia (CAMT) NGS Test This test identifies pathogenic variants in the MPL gene associated with Congenital Amegakaryocytic Thrombocytopenia (CAMT).	Peripheral Whole Blood (DNA Extraction)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MPL gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications"] Indications ["Suspected Congenital Amegakaryocytic Thrombocytopenia (CAMT)", "Family history of inherited thrombocytopenia", "Evaluation of bone marrow failure syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D69.4 Clinical summary This test identifies pathogenic variants in the MPL gene associated with Congenital Amegakaryocytic Thrombocytopenia (CAMT).
TEST-2444 MSX2 Gene Parietal Foramina Type 1 Genetic Test This test identifies pathogenic mutations within the MSX2 gene associated with parietal foramina type 1.	Whole blood (EDTA) or FTA card finger-prick	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MSX2 gene mutations", "Pathogenic variants"] Parameters [] Preparation ["Inform phlebotomist if on anticoagulant therapy", "Do not discontinue prescribed medication without consulting a healthcare provider"] Indications ["Diagnosis of parietal foramina type 1", "Family cascade screening for MSX2 mutations", "Pediatric management of PFM1"] Measurement technique Confirm with laboratory Codes LOINC: 51966-2 ICD-10: Q75.8, Q75.0 Clinical summary This test identifies pathogenic mutations within the MSX2 gene associated with parietal foramina type 1.
TEST-4656 MT-ND5 Gene Genetic Test for Leigh Syndrome (Mitochondrial Complex I Deficiency) This test identifies pathogenic variants within the MT-ND5 gene, which are associated with Leigh syndrome due to mitochondrial complex I deficiency.	Peripheral whole blood (EDTA) or DNA sample (FTA card acceptable)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-ND5 gene", "Mitochondrial Complex I deficiency"] Parameters [] Preparation ["Inform phlebotomist if taking anticoagulants", "Do not discontinue prescribed medication"] Indications ["Suspected Leigh syndrome", "Mitochondrial complex I deficiency", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 93634-8 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants within the MT-ND5 gene, which are associated with Leigh syndrome due to mitochondrial complex I deficiency.
TEST-6030 MVK Gene Mevalonic Aciduria Genetic Test This test analyzes the MVK gene for pathogenic variants associated with mevalonate kinase deficiency (mevalonic aciduria). It provides a definitive molecular diagnosis for this rar...	Whole blood, extracted DNA, or FTA card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MVK gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Suspected mevalonic aciduria based on clinical presentation", "Carrier screening in families with known mutations", "Confirmation following abnormal biochemical screening"] Measurement technique Confirm with laboratory Codes LOINC: 81278-8 ICD-10: E71.1 Clinical summary This test analyzes the MVK gene for pathogenic variants associated with mevalonate kinase deficiency (mevalonic aciduria). It provides a definitive molecular diagnosis for this rare metabolic disorder.
TEST-4101 MYH11 Gene Familial Thoracic Aortic Aneurysm Type 4 Genetic Test This genetic test evaluates the MYH11 gene for pathogenic variants linked to familial thoracic aortic aneurysm type 4.	Whole Blood (EDTA), FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH11 gene coding region"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Individuals with a family history of thoracic aortic aneurysm type 4", "Individuals with unexplained thoracic aortic aneurysm"] Measurement technique Confirm with laboratory Codes LOINC: 84388-5 ICD-10: I71.2 Clinical summary This genetic test evaluates the MYH11 gene for pathogenic variants linked to familial thoracic aortic aneurysm type 4.
TEST-3883 MYH9 Gene (Epstein Syndrome) Genetic Test This test sequences the entire MYH9 gene to detect pathogenic variants associated with Epstein syndrome and related inherited conditions.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH9 gene", "Full gene coverage"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your physician"] Indications ["Suspected Epstein syndrome", "Inherited thrombocytopenia", "Sensorineural hearing loss", "Cataracts", "Progressive kidney disease"] Measurement technique Confirm with laboratory Codes LOINC: 90231-5 ICD-10: D69.1, D72.8, H90.5 Clinical summary This test sequences the entire MYH9 gene to detect pathogenic variants associated with Epstein syndrome and related inherited conditions.
TEST-2054 NCF1 Gene Chronic Granulomatous Disease (Cytochrome b-Positive, Type 1) Genetic Test This genetic test analyzes the NCF1 gene to detect pathogenic variants associated with autosomal recessive Chronic Granulomatous Disease (CGD) type 1.	Peripheral whole blood or FTA card dried blood spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NCF1 gene", "Presence of mutations causing CGD Type 1"] Parameters [] Preparation [] Indications ["Suspected Chronic Granulomatous Disease (CGD) Type 1", "Family history of CGD", "Recurrent severe infections"] Measurement technique Confirm with laboratory Codes LOINC: 21649-1 ICD-10: D82.0 Clinical summary This genetic test analyzes the NCF1 gene to detect pathogenic variants associated with autosomal recessive Chronic Granulomatous Disease (CGD) type 1.
TEST-2703 NGS Albinism Test This diagnostic test evaluates for pathogenic variants in 19+ genes associated with oculocutaneous and syndromic albinism using Next-Generation Sequencing (NGS) and Sanger confirma...	Peripheral Whole Blood	45 working days (expedited reporting available)	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in 19+ albinism-associated genes (OCA1-OCA8, Hermansky-Pudlak, etc.)", "Genetic mutations linked to oculocutaneous and syndromic albinism"] Parameters [] Preparation ["Fasting is not required", "Complete the Whole Exome Sequencing Consent Form (Form 37)", "Present valid Emirates ID and insurance card during home collection"] Indications ["Clinical suspicion of albinism", "Need for precise molecular subtyping for targeted surveillance", "Family planning and recurrence risk assessment", "Differential diagnosis of pigmentary disorders"] Measurement technique Confirm with laboratory Codes LOINC: 20865-3 ICD-10: E70.31 Clinical summary This diagnostic test evaluates for pathogenic variants in 19+ genes associated with oculocutaneous and syndromic albinism using Next-Generation Sequencing (NGS) and Sanger confirmation.
TEST-3895 NLGN3 Gene Autism Susceptibility, X-Linked Type 1 Genetic Test This genetic test evaluates the NLGN3 gene for pathogenic variants associated with X-linked autism spectrum disorder.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NLGN3 gene"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for NLGN3"}] Preparation ["No specific fasting required", "No medication adjustments needed unless directed by a doctor"] Indications ["Suspected X-linked autism spectrum disorder", "Family history of X-linked autism", "Genetic counselling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 96981-1 ICD-10: Z13.89, F84.0 Clinical summary This genetic test evaluates the NLGN3 gene for pathogenic variants associated with X-linked autism spectrum disorder.
TEST-3370 NR5A1 Gene (SPGF8) Genetic Test This test evaluates the NR5A1 gene for variants associated with reproductive disorders.	Whole Blood (EDTA) or Whatman FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NR5A1 gene variants", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"] Parameters [] Preparation ["Mandatory pre-test genetic counseling", "Completion of a detailed family health pedigree"] Indications ["Spermatogenic failure type 8", "46,XY disorders of sex development", "Family history of NR5A1-related reproductive conditions"] Measurement technique Confirm with laboratory Codes LOINC: 90372-6 ICD-10: N46.0, N46.9 Clinical summary This test evaluates the NR5A1 gene for variants associated with reproductive disorders.
TEST-4732 NUBPL Gene Leigh Syndrome Genetic Test This test evaluates the NUBPL gene for mutations associated with Leigh syndrome.	Peripheral Blood (3–5 mL) or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NUBPL gene sequence", "Pathogenic variants in NUBPL gene"] Parameters [] Preparation ["No fasting required", "No specific medication or diet instructions"] Indications ["Suspected Leigh syndrome", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 69261-4 ICD-10: G31.82 Clinical summary This test evaluates the NUBPL gene for mutations associated with Leigh syndrome.
TEST-4570 OFD1 Gene Joubert Syndrome Type 10 Genetic Test This test evaluates the OFD1 gene for variants associated with Joubert syndrome type 10 (JBTS10) and related ciliopathies.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in OFD1 gene", "Small insertions/deletions", "Copy-number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any allergies to blood draw kit components"] Indications ["Suspected Joubert syndrome type 10", "Confirmation of molecular diagnosis", "Family planning", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 82294-1 ICD-10: Q04.3 Clinical summary This test evaluates the OFD1 gene for variants associated with Joubert syndrome type 10 (JBTS10) and related ciliopathies.
TEST-1940 PDGFRA Gene Selective Sequencing of Exons 12, 14, and 18 (NGS) Test This diagnostic test evaluates for specific mutations within exons 12, 14, and 18 of the PDGFRA gene.	Whole blood, Extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFRA gene mutations", "Exon 12 variants", "Exon 14 variants", "Exon 18 variants"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed unless advised by oncologist"] Indications ["Diagnostic confirmation of GIST", "Therapeutic decision-making for GIST", "Identification of actionable mutations in PDGFRA-related malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 93223-7 ICD-10: C49.A Clinical summary This diagnostic test evaluates for specific mutations within exons 12, 14, and 18 of the PDGFRA gene.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.